日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

LONG-TERM EFFICACY AND SAFETY OF PHOTOBIOMODULATION IN DRY AGE-RELATED MACULAR DEGENERATION (LIGHTSITE III: 24-MONTH ANALYSIS)

光生物调节治疗干性年龄相关性黄斑变性的长期疗效和安全性(LIGHTSITE III:24 个月分析)

Jaffe, Glenn J; Boyer, David; Hu, Allen; Warrow, David; Xavier, Samantha; Gonzalez, Victor; Lad, Eleonora; Rosen, Richard B; Do, Diana V; Schneiderman, Todd; Ho, Allen C; Munk, Marion R; Tedford, Stephanie E; Croissant, Cindy L; Rückert, Rene; Lavin, Philip T; Tedford, Clark E

LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System

LIGHTSITE III:使用 Lumithera Valeda 光疗系统对非渗出性(干性)年龄相关性黄斑变性进行多波长光生物调节治疗的 13 个月疗效和安全性评估

Boyer, David; Hu, Allen; Warrow, David; Xavier, Samantha; Gonzalez, Victor; Lad, Eleonora; Rosen, Richard B; Do, Diana; Schneiderman, Todd; Ho, Allen; Munk, Marion R; Jaffe, Glenn; Tedford, Stephanie E; Croissant, Cindy L; Walker, Michael; Rückert, Rene; Tedford, Clark E

Early adoption of triamcinolone acetonide suprachoroidal injection for uveitic macular edema: a physician survey

早期采用曲安奈德脉络膜上腔注射治疗葡萄膜炎性黄斑水肿:一项医生调查

Henry, Christopher R; Walter, Scott D; Chang, Peter Y; Warrow, David J; Naeini, Parisa Emami; Blinder, Kevin J; Brevetti, Teresa; Yassine, Mohamed; Dacey, Mark S; Chu, David S; Raiji, Veena R; Rifkin, Lana M; Shah, Milan; Singer, Michael A

Efficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial

Brolucizumab治疗糖尿病性黄斑水肿的疗效和安全性:KINGFISHER随机临床试验

Singh, Rishi P; Barakat, Mark R; Ip, Michael S; Wykoff, Charles C; Eichenbaum, David A; Joshi, Sunir; Warrow, David; Sheth, Veeral S; Stefanickova, Jana; Kim, Yong Soo; He, Fanyin; Cho, Ga Eun; Wang, Yuhua; Emanuelli, Andrés